Alpro Group launches nationwide thyroid screening campaign in Malaysia
Pharmacy chain Alpro Group launched a national health initiative across Malaysia providing TSH blood screening and referral services to advance early thyroid disease detection
KUALA LUMPUR, MALAYSIA – Alpro Group has announced the launch of Together, We Transform 60+, a nationwide thyroid screening campaign aimed at helping older Malaysians understand their health risks and identify potential thyroid dysfunction earlier. The initiative, supported by Merck Sdn Bhd, focuses on individuals aged 60 and above, particularly those managing hypertension and cholesterol conditions.
Thyroid hormones are crucial for regulating various bodily functions, and abnormal thyroid function can lead to a range of symptoms, including fatigue, memory issues, constipation, muscle aches, and weakness. While these symptoms may be attributed to ageing or existing health conditions, persistent or unexplained symptoms could indicate a thyroid disorder.
Early detection of thyroid dysfunction through TSH screening can facilitate timely clinical assessment and management, potentially preventing complications affecting cardiovascular, metabolic, cognitive, and musculoskeletal health. Alpro Group's community healthcare network will support screening initiatives at retail outlets, guiding individuals with abnormal or borderline results to seek further clinical evaluation.
The programme aims to make thyroid health awareness and screening more accessible, ensuring that at-risk individuals receive appropriate care.
Written by urgent.news from Vietnam Investment Review's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
